カテゴリ： 世界, 医療/バイオ, Market Monitor Global

免疫不全マウスモデルのグローバル市場展望 2023年-2029年：従来型免疫不全モデル、重症免疫不全モデル、次世代型重症免疫不全モデル

■ 英語タイトル：Immunodeficient Mouse Models Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8340）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8340
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[免疫不全マウスモデルのグローバル市場展望 2023年-2029年：従来型免疫不全モデル、重症免疫不全モデル、次世代型重症免疫不全モデル]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の免疫不全マウスモデル市場規模と予測を収録しています。・世界の免疫不全マウスモデル市場：売上、2018年-2023年、2024年-2029年
・世界の免疫不全マウスモデル市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の免疫不全マウスモデル市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「従来型免疫不全モデル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

免疫不全マウスモデルのグローバル主要企業は、The Jackson Laboratory、 Charles River Laboratories、 Taconic Biosciences、 Envigo、 Janvier Labs、 GemPharmatech、 GenOway、 Applied StemCell、 Fred Hutch、 Mary Lyon Centre、 Hera BioLabs、 Champions Oncology、 AXENIS、 Pharmatest、 Lonza、 Biocytogen、 Altogen Labs、 Cyagenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、免疫不全マウスモデルのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の免疫不全マウスモデル市場：タイプ別、2018年-2023年、2024年-2029年
世界の免疫不全マウスモデル市場：タイプ別市場シェア、2022年
・従来型免疫不全モデル、重症免疫不全モデル、次世代型重症免疫不全モデル

世界の免疫不全マウスモデル市場：用途別、2018年-2023年、2024年-2029年
世界の免疫不全マウスモデル市場：用途別市場シェア、2022年
・免疫学、感染症、癌、幹細胞生物学、その他

世界の免疫不全マウスモデル市場：地域・国別、2018年-2023年、2024年-2029年
世界の免疫不全マウスモデル市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における免疫不全マウスモデルのグローバル売上、2018年-2023年
・主要企業における免疫不全マウスモデルのグローバル売上シェア、2022年
・主要企業における免疫不全マウスモデルのグローバル販売量、2018年-2023年
・主要企業における免疫不全マウスモデルのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
The Jackson Laboratory、 Charles River Laboratories、 Taconic Biosciences、 Envigo、 Janvier Labs、 GemPharmatech、 GenOway、 Applied StemCell、 Fred Hutch、 Mary Lyon Centre、 Hera BioLabs、 Champions Oncology、 AXENIS、 Pharmatest、 Lonza、 Biocytogen、 Altogen Labs、 Cyagen

*************************************************************

・調査・分析レポートの概要
免疫不全マウスモデル市場の定義
市場セグメント
世界の免疫不全マウスモデル市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の免疫不全マウスモデル市場規模
世界の免疫不全マウスモデル市場規模：2022年 VS 2029年
世界の免疫不全マウスモデル市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの免疫不全マウスモデルの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の免疫不全マウスモデル製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：従来型免疫不全モデル、重症免疫不全モデル、次世代型重症免疫不全モデル
免疫不全マウスモデルのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫学、感染症、癌、幹細胞生物学、その他
免疫不全マウスモデルの用途別グローバル売上・予測

・地域別市場分析
地域別免疫不全マウスモデル市場規模 2022年と2029年
地域別免疫不全マウスモデル売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
The Jackson Laboratory、 Charles River Laboratories、 Taconic Biosciences、 Envigo、 Janvier Labs、 GemPharmatech、 GenOway、 Applied StemCell、 Fred Hutch、 Mary Lyon Centre、 Hera BioLabs、 Champions Oncology、 AXENIS、 Pharmatest、 Lonza、 Biocytogen、 Altogen Labs、 Cyagen
...

Immunodeficient mice are invaluable tools for immunology, infectious disease, oncology, hematopoietic, and regenerative medicine studies. They can serve as hosts for engraftment of mouse tumor cells, human cancer cell lines, patient-derived xenograft tumors, and many aspects of the human immune system.
This report aims to provide a comprehensive presentation of the global market for Immunodeficient Mouse Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunodeficient Mouse Models. This report contains market size and forecasts of Immunodeficient Mouse Models in global, including the following market information:
Global Immunodeficient Mouse Models Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Immunodeficient Mouse Models Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Immunodeficient Mouse Models companies in 2022 (%)
The global Immunodeficient Mouse Models market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Traditional Immunodeficient Models Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immunodeficient Mouse Models include The Jackson Laboratory, Charles River Laboratories, Taconic Biosciences, Envigo, Janvier Labs, GemPharmatech, GenOway, Applied StemCell and Fred Hutch, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunodeficient Mouse Models manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunodeficient Mouse Models Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immunodeficient Mouse Models Market Segment Percentages, by Type, 2022 (%)
Traditional Immunodeficient Models
Severe Immunodeficient Models
Next-generation Severe Immunodeficient Models
Global Immunodeficient Mouse Models Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immunodeficient Mouse Models Market Segment Percentages, by Application, 2022 (%)
Immunology
Infectious Disease
Cancer
Stem Cell Biology
Other
Global Immunodeficient Mouse Models Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Immunodeficient Mouse Models Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunodeficient Mouse Models revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Immunodeficient Mouse Models revenues share in global market, 2022 (%)
Key companies Immunodeficient Mouse Models sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Immunodeficient Mouse Models sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
The Jackson Laboratory
Charles River Laboratories
Taconic Biosciences
Envigo
Janvier Labs
GemPharmatech
GenOway
Applied StemCell
Fred Hutch
Mary Lyon Centre
Hera BioLabs
Champions Oncology
AXENIS
Pharmatest
Lonza
Biocytogen
Altogen Labs
Cyagen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunodeficient Mouse Models, market overview.
Chapter 2: Global Immunodeficient Mouse Models market size in revenue and volume.
Chapter 3: Detailed analysis of Immunodeficient Mouse Models manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunodeficient Mouse Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Immunodeficient Mouse Models capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Immunodeficient Mouse Models Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunodeficient Mouse Models Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunodeficient Mouse Models Overall Market Size
2.1 Global Immunodeficient Mouse Models Market Size: 2022 VS 2029
2.2 Global Immunodeficient Mouse Models Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Immunodeficient Mouse Models Sales: 2018-2029
3 Company Landscape
3.1 Top Immunodeficient Mouse Models Players in Global Market
3.2 Top Global Immunodeficient Mouse Models Companies Ranked by Revenue
3.3 Global Immunodeficient Mouse Models Revenue by Companies
3.4 Global Immunodeficient Mouse Models Sales by Companies
3.5 Global Immunodeficient Mouse Models Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Immunodeficient Mouse Models Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immunodeficient Mouse Models Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immunodeficient Mouse Models Players in Global Market
3.8.1 List of Global Tier 1 Immunodeficient Mouse Models Companies
3.8.2 List of Global Tier 2 and Tier 3 Immunodeficient Mouse Models Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Immunodeficient Mouse Models Market Size Markets, 2022 & 2029
4.1.2 Traditional Immunodeficient Models
4.1.3 Severe Immunodeficient Models
4.1.4 Next-generation Severe Immunodeficient Models
4.2 By Type – Global Immunodeficient Mouse Models Revenue & Forecasts
4.2.1 By Type – Global Immunodeficient Mouse Models Revenue, 2018-2023
4.2.2 By Type – Global Immunodeficient Mouse Models Revenue, 2024-2029
4.2.3 By Type – Global Immunodeficient Mouse Models Revenue Market Share, 2018-2029
4.3 By Type – Global Immunodeficient Mouse Models Sales & Forecasts
4.3.1 By Type – Global Immunodeficient Mouse Models Sales, 2018-2023
4.3.2 By Type – Global Immunodeficient Mouse Models Sales, 2024-2029
4.3.3 By Type – Global Immunodeficient Mouse Models Sales Market Share, 2018-2029
4.4 By Type – Global Immunodeficient Mouse Models Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Immunodeficient Mouse Models Market Size, 2022 & 2029
5.1.2 Immunology
5.1.3 Infectious Disease
5.1.4 Cancer
5.1.5 Stem Cell Biology
5.1.6 Other
5.2 By Application – Global Immunodeficient Mouse Models Revenue & Forecasts
5.2.1 By Application – Global Immunodeficient Mouse Models Revenue, 2018-2023
5.2.2 By Application – Global Immunodeficient Mouse Models Revenue, 2024-2029
5.2.3 By Application – Global Immunodeficient Mouse Models Revenue Market Share, 2018-2029
5.3 By Application – Global Immunodeficient Mouse Models Sales & Forecasts
5.3.1 By Application – Global Immunodeficient Mouse Models Sales, 2018-2023
5.3.2 By Application – Global Immunodeficient Mouse Models Sales, 2024-2029
5.3.3 By Application – Global Immunodeficient Mouse Models Sales Market Share, 2018-2029
5.4 By Application – Global Immunodeficient Mouse Models Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Immunodeficient Mouse Models Market Size, 2022 & 2029
6.2 By Region – Global Immunodeficient Mouse Models Revenue & Forecasts
6.2.1 By Region – Global Immunodeficient Mouse Models Revenue, 2018-2023
6.2.2 By Region – Global Immunodeficient Mouse Models Revenue, 2024-2029
6.2.3 By Region – Global Immunodeficient Mouse Models Revenue Market Share, 2018-2029
6.3 By Region – Global Immunodeficient Mouse Models Sales & Forecasts
6.3.1 By Region – Global Immunodeficient Mouse Models Sales, 2018-2023
6.3.2 By Region – Global Immunodeficient Mouse Models Sales, 2024-2029
6.3.3 By Region – Global Immunodeficient Mouse Models Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Immunodeficient Mouse Models Revenue, 2018-2029
6.4.2 By Country – North America Immunodeficient Mouse Models Sales, 2018-2029
6.4.3 US Immunodeficient Mouse Models Market Size, 2018-2029
6.4.4 Canada Immunodeficient Mouse Models Market Size, 2018-2029
6.4.5 Mexico Immunodeficient Mouse Models Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Immunodeficient Mouse Models Revenue, 2018-2029
6.5.2 By Country – Europe Immunodeficient Mouse Models Sales, 2018-2029
6.5.3 Germany Immunodeficient Mouse Models Market Size, 2018-2029
6.5.4 France Immunodeficient Mouse Models Market Size, 2018-2029
6.5.5 U.K. Immunodeficient Mouse Models Market Size, 2018-2029
6.5.6 Italy Immunodeficient Mouse Models Market Size, 2018-2029
6.5.7 Russia Immunodeficient Mouse Models Market Size, 2018-2029
6.5.8 Nordic Countries Immunodeficient Mouse Models Market Size, 2018-2029
6.5.9 Benelux Immunodeficient Mouse Models Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Immunodeficient Mouse Models Revenue, 2018-2029
6.6.2 By Region – Asia Immunodeficient Mouse Models Sales, 2018-2029
6.6.3 China Immunodeficient Mouse Models Market Size, 2018-2029
6.6.4 Japan Immunodeficient Mouse Models Market Size, 2018-2029
6.6.5 South Korea Immunodeficient Mouse Models Market Size, 2018-2029
6.6.6 Southeast Asia Immunodeficient Mouse Models Market Size, 2018-2029
6.6.7 India Immunodeficient Mouse Models Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Immunodeficient Mouse Models Revenue, 2018-2029
6.7.2 By Country – South America Immunodeficient Mouse Models Sales, 2018-2029
6.7.3 Brazil Immunodeficient Mouse Models Market Size, 2018-2029
6.7.4 Argentina Immunodeficient Mouse Models Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Immunodeficient Mouse Models Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Immunodeficient Mouse Models Sales, 2018-2029
6.8.3 Turkey Immunodeficient Mouse Models Market Size, 2018-2029
6.8.4 Israel Immunodeficient Mouse Models Market Size, 2018-2029
6.8.5 Saudi Arabia Immunodeficient Mouse Models Market Size, 2018-2029
6.8.6 UAE Immunodeficient Mouse Models Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 The Jackson Laboratory
7.1.1 The Jackson Laboratory Company Summary
7.1.2 The Jackson Laboratory Business Overview
7.1.3 The Jackson Laboratory Immunodeficient Mouse Models Major Product Offerings
7.1.4 The Jackson Laboratory Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.1.5 The Jackson Laboratory Key News & Latest Developments
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Company Summary
7.2.2 Charles River Laboratories Business Overview
7.2.3 Charles River Laboratories Immunodeficient Mouse Models Major Product Offerings
7.2.4 Charles River Laboratories Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.2.5 Charles River Laboratories Key News & Latest Developments
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Company Summary
7.3.2 Taconic Biosciences Business Overview
7.3.3 Taconic Biosciences Immunodeficient Mouse Models Major Product Offerings
7.3.4 Taconic Biosciences Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.3.5 Taconic Biosciences Key News & Latest Developments
7.4 Envigo
7.4.1 Envigo Company Summary
7.4.2 Envigo Business Overview
7.4.3 Envigo Immunodeficient Mouse Models Major Product Offerings
7.4.4 Envigo Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.4.5 Envigo Key News & Latest Developments
7.5 Janvier Labs
7.5.1 Janvier Labs Company Summary
7.5.2 Janvier Labs Business Overview
7.5.3 Janvier Labs Immunodeficient Mouse Models Major Product Offerings
7.5.4 Janvier Labs Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.5.5 Janvier Labs Key News & Latest Developments
7.6 GemPharmatech
7.6.1 GemPharmatech Company Summary
7.6.2 GemPharmatech Business Overview
7.6.3 GemPharmatech Immunodeficient Mouse Models Major Product Offerings
7.6.4 GemPharmatech Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.6.5 GemPharmatech Key News & Latest Developments
7.7 GenOway
7.7.1 GenOway Company Summary
7.7.2 GenOway Business Overview
7.7.3 GenOway Immunodeficient Mouse Models Major Product Offerings
7.7.4 GenOway Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.7.5 GenOway Key News & Latest Developments
7.8 Applied StemCell
7.8.1 Applied StemCell Company Summary
7.8.2 Applied StemCell Business Overview
7.8.3 Applied StemCell Immunodeficient Mouse Models Major Product Offerings
7.8.4 Applied StemCell Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.8.5 Applied StemCell Key News & Latest Developments
7.9 Fred Hutch
7.9.1 Fred Hutch Company Summary
7.9.2 Fred Hutch Business Overview
7.9.3 Fred Hutch Immunodeficient Mouse Models Major Product Offerings
7.9.4 Fred Hutch Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.9.5 Fred Hutch Key News & Latest Developments
7.10 Mary Lyon Centre
7.10.1 Mary Lyon Centre Company Summary
7.10.2 Mary Lyon Centre Business Overview
7.10.3 Mary Lyon Centre Immunodeficient Mouse Models Major Product Offerings
7.10.4 Mary Lyon Centre Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.10.5 Mary Lyon Centre Key News & Latest Developments
7.11 Hera BioLabs
7.11.1 Hera BioLabs Company Summary
7.11.2 Hera BioLabs Immunodeficient Mouse Models Business Overview
7.11.3 Hera BioLabs Immunodeficient Mouse Models Major Product Offerings
7.11.4 Hera BioLabs Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.11.5 Hera BioLabs Key News & Latest Developments
7.12 Champions Oncology
7.12.1 Champions Oncology Company Summary
7.12.2 Champions Oncology Immunodeficient Mouse Models Business Overview
7.12.3 Champions Oncology Immunodeficient Mouse Models Major Product Offerings
7.12.4 Champions Oncology Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.12.5 Champions Oncology Key News & Latest Developments
7.13 AXENIS
7.13.1 AXENIS Company Summary
7.13.2 AXENIS Immunodeficient Mouse Models Business Overview
7.13.3 AXENIS Immunodeficient Mouse Models Major Product Offerings
7.13.4 AXENIS Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.13.5 AXENIS Key News & Latest Developments
7.14 Pharmatest
7.14.1 Pharmatest Company Summary
7.14.2 Pharmatest Business Overview
7.14.3 Pharmatest Immunodeficient Mouse Models Major Product Offerings
7.14.4 Pharmatest Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.14.5 Pharmatest Key News & Latest Developments
7.15 Lonza
7.15.1 Lonza Company Summary
7.15.2 Lonza Business Overview
7.15.3 Lonza Immunodeficient Mouse Models Major Product Offerings
7.15.4 Lonza Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.15.5 Lonza Key News & Latest Developments
7.16 Biocytogen
7.16.1 Biocytogen Company Summary
7.16.2 Biocytogen Business Overview
7.16.3 Biocytogen Immunodeficient Mouse Models Major Product Offerings
7.16.4 Biocytogen Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.16.5 Biocytogen Key News & Latest Developments
7.17 Altogen Labs
7.17.1 Altogen Labs Company Summary
7.17.2 Altogen Labs Business Overview
7.17.3 Altogen Labs Immunodeficient Mouse Models Major Product Offerings
7.17.4 Altogen Labs Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.17.5 Altogen Labs Key News & Latest Developments
7.18 Cyagen
7.18.1 Cyagen Company Summary
7.18.2 Cyagen Business Overview
7.18.3 Cyagen Immunodeficient Mouse Models Major Product Offerings
7.18.4 Cyagen Immunodeficient Mouse Models Sales and Revenue in Global (2018-2023)
7.18.5 Cyagen Key News & Latest Developments
8 Global Immunodeficient Mouse Models Production Capacity, Analysis
8.1 Global Immunodeficient Mouse Models Production Capacity, 2018-2029
8.2 Immunodeficient Mouse Models Production Capacity of Key Manufacturers in Global Market
8.3 Global Immunodeficient Mouse Models Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immunodeficient Mouse Models Supply Chain Analysis
10.1 Immunodeficient Mouse Models Industry Value Chain
10.2 Immunodeficient Mouse Models Upstream Market
10.3 Immunodeficient Mouse Models Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immunodeficient Mouse Models Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ノックアウトマウスモデルのグローバル市場展望 2023年-2029年：KO、cKO
  • 世界の免疫不全マウスモデル市場2022年：市場規模予測（～2028年）
  • ヒト肝臓モデルのグローバル市場展望 2023年-2029年：肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他
  • プロラクチン（PRL）マウスELISAキットのグローバル市場展望 2023年-2029年：診断用オキシトシンマウスELISAキット、研究用オキシトシンマウスELISAキット
  • 世界のノックアウトマウスモデル市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8340 )"免疫不全マウスモデルのグローバル市場展望 2023年-2029年：従来型免疫不全モデル、重症免疫不全モデル、次世代型重症免疫不全モデル" (英文：Immunodeficient Mouse Models Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。